InterventionsHumans5,960 individuals451 daysCohort study

Cardiovascular events with esaxerenone versus spironolactone in hypertension

Journal of Human Hypertension

The paper

Takashin Nakayama, Hidehiro Kaneko, Yuta Suzuki,

Akira Okada, Hiroyuki Morita, Katsuhito Fujiu, Norifumi Takeda, Tatsuhiko Azegami, Takashi Yokoo, Norihiko Takeda, Koichi Node, Hideo Yasunaga,

Keio University

Journal of Human Hypertension · 20 Aug 2026

doi.org/10.1038/s41371-026-01200-2 PubMed 42625028

Low-carb telemedicine links to fewer cardiovascular events
Cardiology and Therapy · 4 Oct 2026
Drug class linked to fewer deaths or complications in kidney disease
The American Journal of Cardiology · 8 Oct 2026
SGLT2 inhibitors link to lower dementia risk than GLP-1 drugs
Diabetes & Vascular Disease Research · 4 Oct 2026
Most US adults meeting PREVENT risk thresholds lack lipid therapy
American Journal of Preventive Cardiology · 4 Oct 2026